PUBLISHER: GlobalData | PRODUCT CODE: 1663614
PUBLISHER: GlobalData | PRODUCT CODE: 1663614
Carotid and Renal Artery Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area. market trends within Cardiovascular Devices therapeutic area.
Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries. Carotid stenosis is further divided into two indications: symptomatic and asymptomatic carotid stenosis. Patients with symptomatic carotid stenosis can present with symptoms such as transient ischemic attacks or temporary vision loss. But in cases of asymptomatic carotid stenosis, there are no such symptoms. Carotid artery stenosis is a major contributor to ischemic stroke. Renal artery stents are expandable tubes that are implanted to increase blood flow in the narrowed renal artery. Renal arteries can become narrowed due to plaque formation in the inner surface of the arteries.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Carotid and Renal Artery Stents and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Cordis Corp, Boston Scientific Corp, Silk Road Medical Inc, Medtronic Plc, Terumo Corp, Cook Medical Inc, Biotronik SE & Co KG, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -